Alerts will be sent to your verified email
Verify Email
PHRMASI
|
Phaarmasia
|
Vivo Bio Tech
|
Vivimed Labs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-9.08 % | 7.43 % | 10.89 % |
|
5yr average Equity Multiplier
|
2.3 | 2.24 | -33.72 |
|
5yr Average Asset Turnover Ratio
|
0.96 | 0.43 | 0.27 |
|
5yr Avg Net Profit Margin
|
-4.04 % | 8.3 % | -54.08 % |
|
Price to Book
|
6.24 | 0.64 | 0.0 |
|
P/E
|
86.39 | 15.26 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
-236.72 Days | 90.56 Days | 184.52 Days |
|
Inventory Days
|
79.69 Days | 72.05 Days | 244.76 Days |
|
Days Receivable
|
83.55 Days | 90.11 Days | 246.32 Days |
|
Days Payable
|
340.86 Days | 88.09 Days | 159.64 Days |
|
5yr Average Interest Coverage Ratio
|
-92.68 | 2.13 | -6.61 |
|
5yr Avg ROCE
|
-8.87 % | 13.85 % | -13.87 % |
|
5yr Avg Operating Profit Margin
|
-5.39 % | 39.67 % | -26.56 % |
|
5 yr average Debt to Equity
|
0.0 | 1.08 | -13.68 |
|
5yr CAGR Net Profit
|
n/a | 5.09 % | -14.97 % |
|
5yr Average Return on Assets
|
-3.86 % | 3.6 % | -10.44 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
73.51 % | 35.16 % | 7.77 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 14.8 % |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -7.0 % | -13.19 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Phaarmasia
|
Vivo Bio Tech
|
Vivimed Labs
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|